Idiopathic Thrombocytopenic Purpura in Post COVID-19 Condition: Case Study

Male, Ch K. V. L. S. N. Anjana and Vyduryam, Kommuri and Yaseswi, N. V. and Pravallika, V. and Akhtar, A. Javed and Christiana, R. Piety and Nissi, P. Joy and Sravya, K. (2021) Idiopathic Thrombocytopenic Purpura in Post COVID-19 Condition: Case Study. Journal of Pharmaceutical Research International, 33 (42A). pp. 25-31. ISSN 2456-9119

[thumbnail of 3193-Article Text-4928-1-10-20221006.pdf] Text
3193-Article Text-4928-1-10-20221006.pdf - Published Version

Download (229kB)

Abstract

A 50 years old woman was referred to hospital with complaints of bluish black discoloration of skin or multiple ecchymosis since 6 days and skin rashes, pink changes or petechiae changes since 1 week, dark color stools since 3 days. She had a history of COVID-19 positive on past ‘‘3 months’’ back and she received the corticosteroids, antiviral drugs, broad spectrum antibiotics, anticoagulants, and vitamin B and C supplements. Now patient is admitted and investigated for further management. Her bone marrow examination reveals marrow cytological features are compatible with immune thrombocytopenic Purpura and peripheral examination reveals red cells are microcytic hypochromic with elongation forms, platelets are markedly reduced and elevation of CRP, reduction of the Hb, PCV, MCH, MCV, MCHC, APTT, Serum vitamin B12, Lymphocytes and her HRCT-Chest shows CORADS 5, Rapid antigen test shows positive. A review on introduction of the disease, etiology, pathogenesis, pathophysiology, mechanism of thrombocytopenia in COVID-19 patients and grading is explained in literature review.

Item Type: Article
Subjects: Asian STM > Medical Science
Depositing User: Managing Editor
Date Deposited: 27 Jan 2023 06:04
Last Modified: 24 Feb 2024 04:13
URI: http://journal.send2sub.com/id/eprint/353

Actions (login required)

View Item
View Item